[1]
“A randomised control trial on the use of bioinstrumentation and rehabilitation technology in hemiplegic patients”, Journal of Pharmaceutical Negative Results, pp. 2996–2999, Oct. 2022, doi: 10.47750/pnr.2022.13.S06.399.